NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002066

Registered date:15/06/2009

Effect of alfha1-adrenoceptor antagonist in lower urinary tract symptoms after high dose brachytherapy for prostate cancer

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedprostate cancer
Date of first enrollment2009/07/01
Target sample size100
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Silodosin take 4mg twice daily after breakfast and dinner immediately before the radiation therapy Silodosin take 4mg twice daily after breakfast and dinner immediately after radiation therapy

Outcome(s)

Primary OutcomeIPSS total score
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum40years-old
Age maximumNot applicable
GenderMale
Include criteria
Exclude criteria1)Having an allergic history of silodosin 2)Having a neuropathic bladder or bladder neck sclerosis or urethral stricture or bladder stone,or sever bladder diverticulum 3)Having an Active urinary tract infection 4)Having a severe ischemic heart disease or cerebrovascular disorder or hepatic disease or renal disease 5)Judged sa being unsuitable for the trial by the doctor

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail
Affiliation Kawasaki Medical School Department of Urology
scientific contact
Name Jou Yoshimasa
Address 577 Matsushima, Kurashiki, Okayama 701-0192 Japan
Telephone
E-mail
Affiliation Kawasaki Medical School Department of Urology